RxDoctor Payments Data

Tracy Morrison, APRN

Family · Anderson, SCNPI 1063826956

Payments from drug & device makers

$1,412in general payments, 2019–2025

Across 110 payments — averaging $12.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$751
  • Boston Scientific$126
  • Otsuka America Pharmaceutical, Inc.$102
  • Axsome Therapeutics, Inc.$95
  • Sunovion Pharmaceuticals Inc.$63
  • Takeda Pharmaceuticals U.S.A., Inc.$62
  • plus $214 from 6 others

What the payments were for

  • Food & beverage$1,412100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,412 in reported general payments places this provider in the 70th percentile of 3,248 family providers in South Carolina.

See all family providers in South Carolina

Medicare billing

Part B allowed, 2024
$5,115
Medicare patients
19
Services billed
74

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl48$71,576
AuvelityDextromethorphan Hbr/Bupropion33$34,633
TrintellixVortioxetine Hydrobromide22$18,467
Lurasidone Hcl45$8,563
Oxcarbazepine115$4,664
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine105$3,506
Aripiprazole30$3,237
Atomoxetine Hcl25$2,530
Clonazepam252$2,319
Duloxetine Hcl131$2,242
Quetiapine Fumarate169$1,744
Fluvoxamine Maleate51$1,583
Fluoxetine Hcl126$1,318
Olanzapine25$1,267
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine20$1,235

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar$751$71,57648 claims
Axsome Therapeutics, Inc.Auvelity$95$34,63333 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$62$18,46722 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 3,248 family providers in South Carolina.

Other family in Anderson

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →